Published in Int J Dev Neurosci on July 09, 2008
Roles of heat shock factor 1 in neuronal response to fetal environmental risks and its relevance to brain disorders. Neuron (2014) 1.03
Strain dependent neurochemical changes induced by embryonic alcohol exposure in zebrafish. Neurotoxicol Teratol (2013) 0.85
Prenatal exposure of ethanol induces increased glutamatergic neuronal differentiation of neural progenitor cells. J Biomed Sci (2010) 0.83
The Genetics of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res (2016) 0.80
Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats. Neurotherapeutics (2015) 0.76
Prenatal alcohol exposure enhances the susceptibility to NMDA-induced generalized tonic-clonic seizures in developing rats. CNS Neurosci Ther (2017) 0.75
Hepatitis C virus infection in an endemic area of Southern Italy 14 years later: evidence for a vanishing infection. Dig Liver Dis (2012) 1.55
Prospective randomized double-blind trial of racecadotril compared with loperamide in elderly people with gastroenteritis living in nursing homes. Eur J Clin Pharmacol (2009) 1.50
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis. J Res Med Sci (2012) 1.47
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments. Epilepsia (2011) 1.20
Adverse effects of atypical antipsychotics in the elderly: a review. Drugs Aging (2006) 1.15
Glutamate metabotropic receptors as targets for drug therapy in epilepsy. Eur J Pharmacol (2003) 1.13
Comparison of the antiepileptogenic effects of an early long-term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy. Epilepsia (2009) 1.11
Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton. J Med Chem (2006) 1.06
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis. BMC Biol (2009) 1.04
Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology (2013) 1.03
Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions. Phytother Res (2013) 1.03
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy. Neuropharmacology (2012) 1.03
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs). Neuropharmacology (2004) 1.01
Hepatotoxicity induced by methimazole in a previously healthy patient. Curr Drug Saf (2009) 0.99
Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy. Epilepsia (2010) 0.99
Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis. Adv Pharmacol Sci (2013) 0.96
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice). Neuropharmacology (2005) 0.96
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis. Mol Neurobiol (2012) 0.95
Lack of efficacy during the switch from brand to generic allopurinol. J Forensic Leg Med (2013) 0.92
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention. Updates Surg (2012) 0.92
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model. Epilepsia (2011) 0.91
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy. Neuropharmacology (2012) 0.91
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. Epilepsy Res (2010) 0.90
Asterixis as a presentation of cerebellar ischemic stroke. West J Emerg Med (2012) 0.88
Use and safety of antipsychotics in behavioral disorders in elderly people with dementia. J Clin Psychopharmacol (2014) 0.88
Solution-phase parallel synthesis of novel 1,2,3,4-tetrahydroisoquinoline-1-ones as anticonvulsant agents. Chem Pharm Bull (Tokyo) (2008) 0.88
Venlafaxine-propafenone interaction resulting in hallucinations and psychomotor agitation. Ann Pharmacother (2008) 0.87
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2004) 0.87
Cerebral stroke injury: the role of cytokines and brain inflammation. J Basic Clin Physiol Pharmacol (2014) 0.86
Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy. Ann Pharmacother (2010) 0.86
Prevalence of Undiagnosed Diabetes in Rheumatoid Arthritis: an OGTT Study. Medicine (Baltimore) (2016) 0.86
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res (2011) 0.85
Epilepsy-induced abnormal striatal plasticity in Bassoon mutant mice. Eur J Neurosci (2009) 0.85
Anticonvulsant profile of flunarizine and relation to Na(+) channel blocking effects. Basic Clin Pharmacol Toxicol (2004) 0.85
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology (2012) 0.85
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice. Pharmacol Biochem Behav (2004) 0.85
Rosacea-like facial rash related to metformin administration in a young woman. BMC Pharmacol Toxicol (2014) 0.85
Spinal myoclonus responsive to topiramate. Mov Disord (2004) 0.84
Neuropharmacology of depression in aging and age-related diseases. Ageing Res Rev (2002) 0.84
Efficacy and safety of off-label use of fondaparinux in the management of heparin-induced thrombocytopenia with thrombosis in an elderly woman. J Clin Pharmacol (2013) 0.84
Effects of acetaminophen and ibuprofen in children with migraine receiving preventive treatment with magnesium. Headache (2013) 0.83
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. Curr Drug Saf (2009) 0.83
Use of topiramate for glossodynia. Pain Med (2007) 0.83
Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res (2012) 0.83
A review on antiepileptic drugs-dependent fatigue: pathophysiological mechanisms and incidence. Eur J Pharmacol (2013) 0.81
Increase in plasma homocysteine levels induced by drug treatments in neurologic patients. Pharmacol Res (2005) 0.81
A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations. BioDrugs (2014) 0.81
Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids. J Med Chem (2003) 0.81
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment. BJU Int (2012) 0.81
Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman. Clin Drug Investig (2004) 0.81
Cocaine dependence and stroke: pathogenesis and management. Curr Neurovasc Res (2015) 0.80
Anti-inflammatory Strategies in Stroke: a Potential Therapeutic Target. Curr Vasc Pharmacol (2016) 0.80
A questionnaire-based study on prevalence and treatment of headache in young children. J Headache Pain (2005) 0.80
Effects of carbamazepine/oxycodone coadministration in the treatment of trigeminal neuralgia. Ann Pharmacother (2011) 0.80
The safety of clozapine in the elderly. Expert Opin Drug Saf (2008) 0.80
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.80
Vigabatrin has antiepileptogenic and antidepressant effects in an animal model of epilepsy and depression comorbidity. Behav Brain Res (2011) 0.80
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease. Eur J Neurosci (2009) 0.80
Melaena following Use of the Cholinesterase Inhibitor Rivastigmine. Clin Drug Investig (2005) 0.79
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Eur J Pharmacol (2002) 0.79
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice: involvement of allopregnanolone biosynthesis. Eur Neuropsychopharmacol (2009) 0.79
Neuroactive steroids and GABAA receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy. J Neurochem (2008) 0.79
Conventional and atypical antipsychotics in the elderly : a review. Clin Drug Investig (2003) 0.79
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical review. Autoimmunity (2014) 0.79
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice. Pharmacol Biochem Behav (2004) 0.79
New AMPA antagonists in epilepsy. Expert Opin Investig Drugs (2012) 0.79
Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology (2006) 0.79
Preclinical activity profile of α-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res (2011) 0.78
Hyperhomocysteinaemia and chronic venous ulcers. Int Wound J (2013) 0.78
New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists. Bioorg Med Chem Lett (2005) 0.78
Adherence to therapy and adverse drug reactions: is there a link? Expert Opin Drug Saf (2014) 0.78
Combined topiramate and declorazepam therapy in a patient affected by essential tremor. Parkinsonism Relat Disord (2006) 0.78
Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy. Expert Opin Ther Targets (2014) 0.78
Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity. Environ Toxicol Pharmacol (2013) 0.78
1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents. Bioorg Med Chem Lett (2003) 0.78
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists. J Chem Inf Comput Sci (2003) 0.78
Role of CYP3A5 in abnormal clearance of methadone. Ann Pharmacother (2008) 0.78